FASN is an androgen-regulated gene in prostate cancer (12) and ERG has been previously described as a pioneer-like factor for AR (37), raising the question of whether AR activity differences in ERG-positive and -negative tumors may underlie the association of FASN with ERG status. This evidence concerns the gene FASN and prostate carcinoma.